Table: Peptidream - Q1 parent results
Nov 7 (Reuters)-
Peptidream Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Sep 30, 2018 Sep 30, 2017 Jun 30, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 555 mln 171 mln
(+224.2 pct) (-78.5 pct)
Operating loss 128 mln loss 1.03
Recurring 54 mln loss 932 mln
Net 33 mln loss 649 mln
EPS 0.27 yen loss 5.51 yen
EPS Diluted 0.25 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Peptidream Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4587.T
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner